Skip to main content
. Author manuscript; available in PMC: 2024 Jan 25.
Published in final edited form as: Int J Pharm. 2022 Dec 21;631:122532. doi: 10.1016/j.ijpharm.2022.122532

Table 1.

Product design parameters for manufacturing LNG-IUSs*.

No. LNG-IUSs with different drug loading Comments
1 0.5% w/w DL Drug loading ranging from 0.5% w/w to 50% w/w was used to investigate the impact on drug release characteristics. 50% w/w drug loading was used as a reference.
2 1% w/w DL
3 2.5% w/w DL-T*
4 2.5% w/w DL-C*
5 5% w/w DL
6 10% w/w DL
7 25% w/w DL
8 50% w/w DL
9 48.8% w/w DL 5% more in excipient amount
10 51.1% w/w DL 5% less in excipient amount
11 47.6% w/w DL 10% more in excipient amount
12 52.6% w/w DL 10% less in excipient amount
*

T and C represent the API obtained from Tecoland and Cayman, respectively. API from Tecoland was used in the formulations without T or C.